Key terms
About PRPH
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PRPH news
Mar 19
10:38am ET
ProPhase Labs rating moved to under review at H.C. Wainwright
Mar 15
8:13am ET
ProPhase Labs sees significant sequential improvement in revenues going forward
Mar 15
8:11am ET
ProPhase Labs reports 2023 EPS (98c) vs. $1.02 last year
Feb 21
12:00pm ET
Analysts Offer Insights on Healthcare Companies: Prophase Labs (PRPH) and Crispr Therapeutics AG (CRSP)
Feb 20
8:15am ET
ProPhase Labs announces significant progress in BE-SMART test development
Feb 15
6:27am ET
Buy Rating for Prophase Labs on Strong Clinical Trial Results and Manufacturing Expansion
Feb 14
8:23am ET
ProPhase Labs announces preliminary results for dietary supplement Equivir
Jan 30
8:15am ET
ProPhase Labs announces Karkus became President of Nebula Genomics
Jan 23
8:12am ET
ProPhase Labs announces significant progress at PMI
Jan 04
8:08am ET
ProPhase Labs appoints Latkin as COO
No recent press releases are available for PRPH
PRPH Financials
Key terms
Ad Feedback
PRPH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PRPH Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
